pr-inside.com
Print
Chugai Pharmaceutical Co Ltd - PharmaVitae Profile

Chugai Pharmaceutical Co Ltd - PharmaVitae Profile - http://www.companiesandmarkets.com adds new report



2008-09-04 23:47:02 - Chugai Pharmaceutical Co Ltd - PharmaVitae Profile - a new market research report on www.companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/Chugai-Pharm ..

Introduction

This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

*Benchmark Chugai´s performance against key rivals in the

 

 

prescription pharmaceutical sector

*Evaluate the impact of Chugai´s alliance with Roche, including forecast strong growth for the Avastin franchise in Japan

*Assess the forecast performance of Actemra, the first monoclonal antibody product to be developed and successfully launched by a Japanese company


www.companiesandmarkets.com/Summary-Company-Profile/Chugai-Pharm ..

Author:
Mike King
e-mail
Web: http://www.companiesandmarkets.com
Telefon: London: +44 (0) 203 086 8600




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.